8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-20-016095
Results of operations
- Item 2.02 Results of operations and financial condition
From the SEC's structured data for this filing
Loading a8-kq32020pressrelease.htm…